Streptozocin CAS:18883-66-4 Manufacturer Price

Streptozocin is primarily used in the treatment of pancreatic islet cell cancer, which is a rare type of cancer that affects the insulin-producing cells of the pancreas. It is also sometimes used in the treatment of metastatic neuroendocrine tumors.

Streptozocin works by disrupting the DNA structure of cancer cells, which prevents them from dividing and growing. It specifically targets the beta cells of the pancreas. By destroying these cells, streptozocin can help to reduce the size of the tumor and slow down its progression.

Streptozocin is usually administered intravenously in a healthcare setting. The dosage and treatment schedule may vary depending on individual factors, such as the stage of cancer and the patient's overall health. It is often used in combination with other chemotherapy drugs to maximize its effectiveness.